Stock 3N9 AMRYT PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

News Amryt Pharma Deutsche Boerse AG

Equities

3N9

GB00BKB1MS30

Delayed Deutsche Boerse AG
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for Amryt Pharma -.--% -.--%
2021 Amryt Pharma to Delist from LSE's Main Market in January 2022 MT
2021 Amryt Pharma : Boosts FY21 Revenue Guidance Following Chiasma Purchase MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Amryt Pharma to Delist from LSE's Main Market in January 2022
MT
Amryt Pharma : Boosts FY21 Revenue Guidance Following Chiasma Purchase
MT
Amryt Pharma : Hikes FY21 Guidance As H1 Loss Narrows On Strong Growth
MT
Amryt Pharma : Completes Acquisition Of Chiasma
MT
Novacyt : CEO to Retire; Amryt Pharma Exec Named Successor
MT
Amryt Pharma : Sends Invitation To Shareholders To Vote For Chiasma Acquisition
MT
Amryt Pharma : Wins US FDA's Priority Review Status For Rare Genetic Skin Disorder Drug
MT
Amryt Pharma : Receives New Drug Application Status For Oleogel-S10 In US
MT
Amryt Pharma : Submits New Rare Disease Drug for US FDA Approval
MT
Amryt Pharma : Reports Encouraging Results From Familial Chylomicronaemia Syndrome Drug Trial
MT
Amryt Pharma : Shares Rise 5% on European Medicines Agency Progress for Skin Disorder Drug
MT
Amryt Pharma : Seeks to Double Leptin Deficiency Drug Myalepta's Market Share in US
MT
Amryt Pharma : Myalepta Receives Reimbursement Approval in France
MT
Amryt Pharma : Agrees Distribution of Myalepta In Canada
MT
Amryt Pharma : Myalepta Receives Reimbursement Approval in England, Wales
MT
Amryt Pharma : Jumps 5% On US FDA Orphan Drug Designation For Skin Disease Treatment
MT
Amryt Pharma : Receives Marketing Authorization in Brazil for Cholesterol Treatment Lojuxta
MT
Amryt Pharma : Plans $40 Million Capital Raising for Working Capital, Potential Acquisitions
MT
Reverse Split: 1 of 6
FA
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3N9 Stock
  4. 3N9 Stock
  5. News Amryt Pharma
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW